Evidence map›Paper›PMID 34696842›Full record

ArticleAdvances in parasitology2021

Towards global control of parasitic diseases in the Covid-19 era: One Health and the future of multisectoral global health governance.

Lawson Ung, J Russell Stothard, Revati Phalkey, Andrew S Azman, James Chodosh, William P Hanage, Claire J Standley

Open access · greenAbstract read
In one paragraph

Article in Advances in parasitology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
24.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. TheMolecular biology of the cell · 2025
    Article
  4. ThebioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tropical medicine and infectious disease · 2023
    Review
  11. Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  12. Development of the WeChat Public AccountJournal of medical education and curricular development
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Lawson UngInfectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States; Department of Epidemiology and Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, MA, United States.
J Russell StothardDepartment of Tropical Disease Biology, Center for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Revati PhalkeyDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Andrew S AzmanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
James ChodoshInfectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States.
William P HanageDepartment of Epidemiology and Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, MA, United States. Electronic address: whanage@hsph.harvard.edu.
Claire J StandleyHeidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany; Center for Global Health Science and Security, Georgetown University, Washington, DC, United States. Electronic address: claire.standley@georgetown.edu.
Harvard University · USCenter for Disease Dynamics, Economics & Policy · USGeorgetown University · USLiverpool School of Tropical Medicine · GBUniversity of Geneva · CHUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human parasitic infections-including malaria, and many neglected tropical diseases (NTDs)-have long represented a Gordian knot in global public health: ancient, persistent, and exceedingly difficult to control. With the coronavirus disease (Covid-19) pandemic substantially interrupting control programmes worldwide, there are now mounting fears that decades of progress in controlling global parasitic infections will be undone. With Covid-19 moreover exposing deep vulnerabilities in the global health system, the current moment presents a watershed opportunity to plan future efforts to reduce the global morbidity and mortality associated with human parasitic infections. In this chapter, we first provide a brief epidemiologic overview of the progress that has been made towards the control of parasitic diseases between 1990 and 2019, contrasting these fragile gains with the anticipated losses as a result of Covid-19. We then argue that the complementary aspirations of the United Nations Sustainable Development Goals (SDGs) and the World Health Organization (WHO)'s 2030 targets for parasitic disease control may be achieved by aligning programme objectives within the One Health paradigm, recognizing the interdependence between humans, animals, and the environment. In so doing, we note that while the WHO remains the preeminent international institution to address some of these transdisciplinary concerns, its underlying challenges with funding, authority, and capacity are likely to reverberate if left unaddressed. To this end, we conclude by reimagining how models of multisectoral global health governance-combining the WHO's normative and technical leadership with greater support in allied policy-making areas-can help sustain future malaria and NTD elimination efforts.

Indexed as

COVID-19One HealthParasitic DiseasesTropical MedicineAnimalsGlobal HealthHumansNeglected DiseasesSARS-CoV-2COVID-19Global health governanceMalariaNeglected tropical diseasesOne HealthSustainable Development Goals (SDGs)World Health Organization (WHO)

Identifiers

PMID34696842
PMCPMC8503781
OpenAlexW3206307233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.